为什么 2026 年是生物技术行业的复苏之年
该行业的逆风正在消散。这对寻求流动性的风险投资公司以及希望寻找增长故事的股市来说都是好消息，Nilesh Kumar 在一篇客座评论中写道
Headwinds in the sector are clearing. That is good news for venture firms seeking liquidity and for a stock market looking for growth stories, Nilesh Kumar writes in a guest commentary.